BEIJING WANTAI BIOLOGICAL PHARMACY revenue breakdown overview

BEIJING WANTAI BIOLOGICAL PHARMACY revenue for the last year amounted to 2.78 B CNY, the most of which — 1.88 B CNY — came from its highest performing source at the moment, Diagnostic, the year earlier bringing 1.81 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING WANTAI BIOLOGICAL PHARMACY 2.00 B CNY, and the year before that — 5.34 B CNY.